Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide
Martin Reck, Tony Mok, Aaron S. Mansfield, Richard de Boer, György Losonczy, Shunichi Sugawara, Rafał Dziadziuszko, Maciej Krzakowski, Alexey Smolin, Maximilian J. Hochmair, Marina Chiara Garassino, Gilberto de Castro, Helge Bischoff, Sivuonthanh Lam, Andrés F. Cardona, Stefanie Morris, Stephen V. Liu
Topics & Concepts
AtezolizumabMedicinePlaceboMaintenance therapyHazard ratioInternal medicineOncologyCarboplatinPopulationChemotherapyCancerConfidence intervalImmunotherapyPembrolizumabPathologyCisplatinEnvironmental healthAlternative medicineLung Cancer Research StudiesIntraperitoneal and Appendiceal MalignanciesPARP inhibition in cancer therapy